We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Therapy Reduces Risk of Death by 42% in Study of Patients With Common Liver Cancer

News   May 14, 2020 | Original story from UCLA Health

 
Therapy Reduces Risk of Death by 42% in Study of Patients With Common Liver Cancer
 
 
Advertisement
 

RELATED ARTICLES

Strengthening the Body's Defenses Against Adenoviruses

News

Scientist have show that an already approved drug from cancer treatment could help against adenovirus infection by strengthening the body's viral defenses.

READ MORE

Single Dose of Tocilizumab Linked to 45% Lower Risk of Dying Among COVID-19 Patients on Ventilators

News

Critically ill COVID-19 patients who received a single dose of intravenous tocilizumab were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn't receive the drug, according to new research conducted by University of Michigan scientists.

READ MORE

New Strategy To Stop the Spread of Childhood Bone Cancer

News

A set of key genes has been discovered that drive bone cancer spread to the lungs in patients. In mice with engineered human bone cancer cells that lack these key genes, the cancer could not spread to the lungs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE